Circulating periostin in patients with nonalcoholic fatty liver disease

Endocrine. 2017 May;56(2):438-441. doi: 10.1007/s12020-016-1144-x. Epub 2016 Oct 13.

Authors

Stergios A Polyzos¹, Jannis Kountouras², Athanasios D Anastasilakis³, Athanasios Papatheodorou⁴, Panagiotis Kokkoris⁴, Evangelos Terpos⁵

Affiliations

¹ Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. [email protected].
² Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
⁴ Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
⁵ Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece.

PMID: 27738886
DOI: 10.1007/s12020-016-1144-x

No abstract available

Publication types

Letter

MeSH terms

Adiposity
Biomarkers / blood
Biopsy
Body Mass Index
Cell Adhesion Molecules / blood*
Cross-Sectional Studies
Down-Regulation*
Female
Humans
Liver / pathology
Liver / physiopathology*
Liver Cirrhosis / etiology*
Liver Cirrhosis / pathology
Liver Cirrhosis / physiopathology
Male
Middle Aged
Non-alcoholic Fatty Liver Disease / blood*
Non-alcoholic Fatty Liver Disease / diagnosis
Non-alcoholic Fatty Liver Disease / etiology
Non-alcoholic Fatty Liver Disease / physiopathology
Obesity / physiopathology
Overweight / physiopathology
Pilot Projects
Predictive Value of Tests
Sensitivity and Specificity
Severity of Illness Index
Waist Circumference

Substances

Biomarkers
Cell Adhesion Molecules
POSTN protein, human